IMC Chicago
HRMY icon

IMC Chicago’s Harmony Biosciences HRMY Stock Holding History

IMC Chicago’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,765
Closed -$371K – 6533
2026
Q1 		$330K Buy
+11,765
New +$386K ﹤0.01% 4481

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

IMC Chicago's HRMY Position: Q2 2026 in Review

IMC Chicago sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 11,765 shares — an estimated $371K sold.

IMC Chicago first reported a position in HRMY in Q1 2026 and held it in 1 quarter. The position peaked at $330K in Q1 2026. 124 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • IMC Chicago reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 11,765 Harmony Biosciences shares in Q2 2026, an estimated $371K.
  • IMC Chicago first reported a position in Harmony Biosciences in Q1 2026 and held it in 1 quarter.
  • IMC Chicago's Harmony Biosciences position peaked at $330K in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.